Benefit-Risk Assessment of Ropivacaine in the Management of Postoperative Pain
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 27 (14) , 1093-1114
Abstract
Ropivacaine is a long-acting amide-type local anaesthetic, released for clinical use in 1996. In comparison with bupivacaine, ropivacaine is equally effective for subcutaneous infiltration, epidural...Keywords
This publication has 218 references indexed in Scilit:
- Efficacy of ropivacaine compared with ropivacaine plus sufentanil for postoperative analgesia after major knee surgeryAnaesthesia, 2002
- Problems of diagnostic assessment in low back patientsDer Schmerz, 2001
- Ropivacaine, 0.1%, Plus Sufentanil, 0.5 μg/ml, versus Bupivacaine, 0.1%, Plus Sufentanil, 0.5 μg/ml, Using Patient-controlled Epidural Analgesia for LaborAnesthesiology, 2000
- Ropivacaine‐clonidine combination for caudal blockade in childrenActa Anaesthesiologica Scandinavica, 2000
- Motor blockade is reduced with ropivacaine 0.125% for parturient-controlled epidural analgesia during labourCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1999
- A double-blind study of axillary brachial plexus block by 0.75% ropivacaine or 2% mepivacaineEuropean Journal of Anaesthesiology, 1998
- Spinal anesthesia for outpatients: Appropriate agents and techniquesJournal of Clinical Anesthesia, 1995
- Adverse Effects of Local AnaestheticsDrug Safety, 1992
- Effect of intradermal injection of saline or a local anaesthetic agent on skin blood flow – a methodological study in manActa Anaesthesiologica Scandinavica, 1991
- Muscle Atrophy following Nerve Block TherapyAnesthesiology, 1988